Search

1201004
1195994
393884
209802
1197163
Community Engagement
In March 2016 SATVI brought "Lienkie se Longe", a drama to raise awareness about TB, to the Worcester Easter Festival. The drama tells the story of Lienkie, whose lungs “talk with each other’ about their health and the health of Lienkie’s boyfriend...
Biomarker discovery offers hope for new TB vaccine development
A team of scientists from the University of Cape Town, Oxford University and the London School of Hygiene & Tropical Medicine have made a discovery that reveals how we can improve development of more effective vaccines against tuberculosis.
Community Engagement
In 2012 SATVI developed a drama production to promote awareness about TB vaccine clinical research, titled “Carina’s Choice” with learners from Worcester Secondary School as actors and UCT drama school students as mentors. A very successful roadshow...
Accredited UCT Research Centre
The South African Tuberculosis Vaccine Initiative (SATVI) is an accreditated Research Centre of the University of Cape Town.
Kick TB Schools Program 17- 27 May 2016
On Tuesday 17 May 2016, SATVI kicked off a districtwide TB awareness raising program, in partnership with TB Alliance, the Western Cape Education Department, AERAS, TB Care (USAID), in Robertson.

News

Wednesday, 16 August 2017
15 August 2017 NEW VACANCY: Laboratory Technologist

South African Tuberculosis Vaccine Initiative (SATVI), located within Infectious Disease and Molecular Medicine (IDM) at the Faculty of Health Sciences invites applications from suitably qualified candidates for a 24-month contract position of Laboratory Technologist based in Worcester.

Publication Date:
Tuesday, August 15, 2017 - 14:30
14 August 2017 LATEST RESEARCH: Optimization and interpretation of serial QuantiFERON testing to measure acquisition of M. tuberculosis infection

SATVI authors have published research in which they find that the implementation of optimized procedures and a more rigorous QuantiFERON-TB conversion definition, an increase from IFNy<0.2 to >0.7 IU/mL, would allow more definitive detection of recent M.tb infection and potentially improve identification of those more likely to develop disease.

Publication Date:
Tuesday, August 15, 2017 - 13:15
9 August 2017 SATVI hosts delegation from the Cape Winelands Education Department

On Thursday 3 August the South African Tuberculosis Vaccine Initiative hosted a delegation from the Cape Winelands Education TB & HIV Program.

Publication Date:
Tuesday, August 15, 2017 - 11:45
7 August 2017 Research Published: Differential Recognition of Mtb-specific Epitopes as a Function of Tuberculosis Disease History

SATVI authors Professor Mark Hatherill, Associate Professor Tom Scriba,  Drs. Munyaradzi Musvosvi and Virginie Rozoton have co-authored a research paper titled "Differential recognition of Mtb-specific epitopes as a function of tuberculosis disease history" appearing in the American Journal of Respiratory and Critical Care Medicine.

Publication Date:
Monday, August 14, 2017 - 22:15

Pages